BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16227164)

  • 1. Diagnostic delay in primary central nervous system lymphoma.
    Haldorsen IS; Espeland A; Larsen JL; Mella O
    Acta Oncol; 2005; 44(7):728-34. PubMed ID: 16227164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
    Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA
    Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
    Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
    Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
    Salvesen Haldorsen I; Aarseth JH; Hollender A; Larsen JL; Espeland A; Mella O
    Acta Oncol; 2004; 43(6):520-9. PubMed ID: 15370608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of brain magnetic resonance studies in the diagnostics of central nervous system lesions in HIV-1 positive patients].
    Sokolska V; Knysz B; Czapiga E; Gasiorowski J; Sasiadek M; Gładysz A
    Wiad Lek; 2006; 59(11-12):805-13. PubMed ID: 17427496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
    Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
    Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
    Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
    Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of diagnosis and treatment for primary central nervous system lymphoma].
    Meng FG; Zhang K; Mao GS; Wang ZC; Wu CY; Liu K
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1549-52. PubMed ID: 18282393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A retrospective analysis of 8 cases with primary central nervous system lymphoma].
    Zhou XQ; Liu XQ; Kong JC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):455-7. PubMed ID: 12905861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular manifestation of primary nervous system lymphoma: what can be expected from imaging?
    Küker W; Herrlinger U; Grönewäller E; Rohrbach JM; Weller M
    J Neurol; 2002 Dec; 249(12):1713-6. PubMed ID: 12529795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-grade primary central nervous system lymphoma in immunocompetent patients.
    Jahnke K; Thiel E; Schilling A; Herrlinger U; Weller M; Coupland SE; Krümpelmann U; Stein H; Korfel A
    Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
    Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
    Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stereotactic brain biopsy in the diagnosis of focal brain lesions in AIDS].
    Corti M; Metta H; Villafañe MF; Yampolsky C; Schtirbu R; Sevlever G; Garrido D
    Medicina (B Aires); 2008; 68(4):285-90. PubMed ID: 18786884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary central nervous system lymphomas: a 30-year experience at a single institution.
    Nuckols JD; Liu K; Burchette JL; McLendon RE; Traweek ST
    Mod Pathol; 1999 Dec; 12(12):1167-73. PubMed ID: 10619271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
    Bossolasco S; Falk KI; Ponzoni M; Ceserani N; Crippa F; Lazzarin A; Linde A; Cinque P
    Clin Infect Dis; 2006 Feb; 42(4):e21-5. PubMed ID: 16421782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of primary central nervous system lymphoma related to AIDS in the HAART era.
    González-Aguilar A; Soto-Hernández JL
    Curr Opin Oncol; 2011 Nov; 23(6):648-53. PubMed ID: 21946245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary lymphoma of the central nervous system: 20 years' experience in a referral hospital].
    Calderón-Garcidueñas AL; Pacheco-Calleros J; Castelán-Maldonado E; Nocedal-Rustrián FC
    Rev Neurol; 2008 Jan 16-31; 46(2):84-8. PubMed ID: 18247279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
    Cingolani A; Fratino L; Scoppettuolo G; Antinori A
    J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
    Zacharia TT; Law M; Naidich TP; Leeds NE
    J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.